Skip to Main Content

Paper Details

GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.
J Neuropathol Exp Neurol
16
2019
-, -ROS1 fusion, 6q22, GOPC, Glioneuronal Tumors, Pediatric Gliomas, ROS1, ROS1 Fusion, ROS1 fusion, chromosome 6q22 microdeletions, glioblastoma, neoplasms, pediatric glioma, synaptophysin, transmembrane receptor tyrosine kinase proto-oncogene, tumor, tumors, tyrosine, tyrosine kinase
Author NameAffiliation
Kanish MirchiaNationwide Children's Hospital and The Ohio State University.
Christopher R PiersonNationwide Children's Hospital, The Institute for Genomic Medicine
Mohamed S AbdelbakiState University of New York, Upstate Medical University
Mohamed S AbdelbakiState University of New York, Upstate Medical University
Kathleen M SchiefferWaters Center for Children's Cancer and Blood Disorders, State University of New York, Upstate Cancer Center
Catherine E CottrellState University of New York, Upstate Medical University
Daniel R Bou??Nationwide Children's Hospital and The Ohio State University.
Daniel R Bou??Nationwide Children's Hospital and The Ohio State University.
  • 1 - 8

Datasets

Release 1.2